Shares of Biohaven fell more than 40% on Wednesday after the U.S. Food and Drug Administration declined to approve its experimental treatment for a rare brain disorder.

FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia

08:06pm, Tuesday, 04'th Nov 2025

The troriluzole clinical development program encompassed the first industry clinical trials to generate data showing therapeutic potential in patients with spinocerebellar ataxia (SCA), a rare geneti

Biohaven Ltd. (NYSE:BHVN) Given Consensus Recommendation of “Buy” by Analysts

02:33am, Thursday, 23'rd Oct 2025

Shares of Biohaven Ltd. (NYSE: BHVN - Get Free Report) have been given a consensus recommendation of "Buy" by the sixteen analysts that are currently covering the firm, Marketbeat reports. One investm

BHVN FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Biohaven Ltd. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action – BHVN

10:00am, Friday, 12'th Sep 2025

NEW YORK, Sept. 12, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Biohaven Ltd. (NYSE: BHVN) between March 24, 2023 and May 14,

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

09:49am, Friday, 12'th Sep 2025

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Biohaven To Contact Him Directly To Discuss Their Options

Biohaven Ltd. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before September 12, 2025 to Discuss Your Rights - BHVN

08:45am, Friday, 12'th Sep 2025

NEW YORK , Sept. 12, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Biohaven Ltd.

BHVN Deadline: BHVN Investors Have Opportunity to Lead Biohaven Ltd. Securities Fraud Lawsuit

07:40pm, Thursday, 11'th Sep 2025

NEW YORK , Sept. 11, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Biohaven Ltd.

Lost Money on Biohaven Ltd. (BHVN) Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky

04:21pm, Thursday, 11'th Sep 2025

NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Biohaven Ltd. ("Biohaven Ltd." or the "Company") (NYSE: BHVN) of a class action securities lawsuit.

BHVN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biohaven Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

04:00pm, Thursday, 11'th Sep 2025

NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed

Deadline Soon: Biohaven Ltd. (BHVN) Investors Who Lost Money Urged To Contact The Law Offices of Frank R.

12:43pm, Thursday, 11'th Sep 2025

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming September 12, 2025 deadline to participate as a lead plaintiff in the securities fraud class action law

Shareholders that lost money on Biohaven Ltd.(BHVN) Urged to Join Class Action - Contact The Gross Law Firm to Learn More

08:45am, Thursday, 11'th Sep 2025

NEW YORK , Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Biohaven Ltd.

BIOHAVEN FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Biohaven Investors of the September 12th Deadline to File in the Class Action Lawsuit

07:43am, Thursday, 11'th Sep 2025

The complaint alleges Biohaven overstated troriluzole's approval chances and BHV-7000's efficacy, misleading investors on its business and prospects.

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by